172 related articles for article (PubMed ID: 2837183)
1. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Wiznitzer A; Marbach M; Hazum E; Insler V; Sharoni Y; Levy J
Biochem Biophys Res Commun; 1988 May; 152(3):1326-31. PubMed ID: 2837183
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue.
Sion-Vardi N; Kaneti J; Segal-Abramson T; Giat J; Levy J; Sharoni Y
J Urol; 1992 Nov; 148(5):1568-70. PubMed ID: 1331544
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
[No Abstract] [Full Text] [Related]
4. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of agonist- and antagonist-occupied gonadotropin-releasing hormone receptors to protein kinase C activators. A marker for receptor activation.
Huckle WR; McArdle CA; Conn PM
J Biol Chem; 1988 Mar; 263(7):3296-302. PubMed ID: 2830280
[TBL] [Abstract][Full Text] [Related]
7. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
8. Guanine nucleotide modulation of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors.
Segal-Abramson T; Giat J; Levy J; Sharoni Y
Mol Cell Endocrinol; 1992 May; 85(1-2):109-16. PubMed ID: 1326449
[TBL] [Abstract][Full Text] [Related]
9. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: I. Characterization, properties and ligand specificity.
Bramley TA; McPhie CA; Menzies GS
Placenta; 1992; 13(6):555-81. PubMed ID: 1338344
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists.
Eidne KA; Flanagan CA; Harris NS; Millar RP
J Clin Endocrinol Metab; 1987 Mar; 64(3):425-32. PubMed ID: 3029154
[TBL] [Abstract][Full Text] [Related]
11. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: III. Changes in GnRH binding levels with stage of gestation.
Bramley TA; McPhie CA; Menzies GS
Placenta; 1994 Oct; 15(7):733-45. PubMed ID: 7838829
[TBL] [Abstract][Full Text] [Related]
12. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors.
Imai A; Takagi H; Horibe S; Fuseya T; Tamaya T
J Clin Endocrinol Metab; 1996 Sep; 81(9):3249-53. PubMed ID: 8784077
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
14. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
Srkalovic G; Wittliff JL; Schally AV
Cancer Res; 1990 Mar; 50(6):1841-6. PubMed ID: 2155060
[TBL] [Abstract][Full Text] [Related]
15. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells.
Mullen P; Bramley T; Menzies G; Miller B
Eur J Cancer; 1993; 29A(2):248-52. PubMed ID: 8380699
[TBL] [Abstract][Full Text] [Related]
16. Distribution of gonadrotropin releasing hormone agonist binding sites in the rat central nervous system.
Jennes L; Dalati B; Conn PM
Brain Res; 1988 Jun; 452(1-2):156-64. PubMed ID: 2841008
[TBL] [Abstract][Full Text] [Related]
17. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
Emons G; Ortmann O; Becker M; Irmer G; Springer B; Laun R; Hölzel F; Schulz KD; Schally AV
Cancer Res; 1993 Nov; 53(22):5439-46. PubMed ID: 8221683
[TBL] [Abstract][Full Text] [Related]
18. Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinomata.
Pahwa GS; Kullander S; Vollmer G; Oberheuser F; Knuppen R; Emons G
Eur J Obstet Gynecol Reprod Biol; 1991 Sep; 41(2):135-42. PubMed ID: 1657655
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
20. Effect of purified 31K bovine inhibin on the specific binding of gonadotropin-releasing hormone to rat anterior pituitary cells in culture.
Wang QF; Farnworth PG; Findlay JK; Burger HG
Endocrinology; 1988 Nov; 123(5):2161-6. PubMed ID: 2844504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
